Navigation Links
International team analyzes human genetic variation in key immune region

An international group of researchers today unveiled a detailed map of human genetic variation within the major histocompatibility complex (MHC), the most important region of the human genome encoding the human response to infection, autoimmune disease and organ transplantation. The work represents a milestone in the analysis of genetic variability for this fundamental immune region and lays the scientific foundation for future efforts aimed at uncovering the genetic roots of immune-related diseases. The findings of this international team, which includes scientists from the Montreal Heart Institute (MHI), the Université de Montréal (UdeM), the Broad Institute of MIT and Harvard and several other research institutions, appear in the September 24 advance online edition of Nature Genetics.

"This new map will be a key resource for researchers to use to find genes affecting health, disease, and responses to medications," said senior author Dr. John D. Rioux, PhD, who is associate professor of medicine at the UdeM and at the MHI where he works as a researcher and director of the Laboratory in Genetics and Genomic Medicine of Inflammation (www.inflammgen.org), visiting scientist of the Broad Institute of MIT and Harvard, and holder of the Canada Research Chair in Genetics and Genomic Medicine of Inflammation. "It will provide the information necessary to design powerful studies to identify the genetic risk factors located within the MHC."

The MHC -- specifically, the genes that comprise it -- is associated with more diseases than any other region of the human genome. This includes common diseases such as atherosclerosis, arthritis, diabetes, HIV, lupus, multiple sclerosis and Crohn's disease. However, pinpointing the specific changes that are causative in these diseases has been complicated by two factors: the extremely high degree of genetic diversity that exists in the MHC among different individuals and the tend
'"/>

Source:University of Montreal


Page: 1 2 3

Related biology news :

1. International trial of two microbicides begins
2. International HapMap consortium expands mapping effort
3. Solutions that reduce death of marine life reeled in by International Smart Gear Competition
4. International Team Determines Geographic Origin of Leprosy
5. International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy
6. Novel technology detects human DNA mutations
7. Current human embryonic stem cell lines contaminated UCSD/Salk team finds
8. UWs Rosetta software to unlock secrets of many human proteins
9. Genome-wide mouse study yields link to human leukemia
10. Found: Missing sequence of the human Y chromosome
11. Study finds more than one-third of human genome regulated by RNA

Post Your Comments:
(Date:11/24/2009)... Antarctica has long held secrets of the earth,s ...ly, there has been very little information on the ...f ice for millions of years. Now, a team of resear...been funded to the tune of $10 million dollars by ... the bottom of things literally. These scientists...
(Date:11/23/2009)... research presents strong evidence that the "syner...oor traffic-related pollution and indoor endotoxin...the other exposure alone. , Environmental heal... College of Medicine have shown that children expo...es and indoor endotoxin during early life are six ...
(Date:11/23/2009)... by the Wildlife Conservation Society says that we...the Republic of Congopart of the "mother lode" of ... becoming increasingly threatened by growing human... protection of the swamp forests adjacent to the s...recent surveys confirmed that high densities of th...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 13118 1Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 13118 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 1Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 3Next Generation Hemostatic Dressing Available for Military Emergencies 52198 1Next Generation Hemostatic Dressing Available for Military Emergencies 52198 2Next Generation Hemostatic Dressing Available for Military Emergencies 52198 3
...e confident, comfortable and flexible with their e...of cardiovascular disease than people who are not....um that helps people understand their eating habit... therapy. , "We wanted to see if people were at h... they were not eating competent to begin with," sa...
...enture capitalist Vinod Khosla told last years Bio...iversity why he believes fuel blends containing 85... supply. , Khosla who last year told The New Yo...in private companies developing ethanol production...al and special interest groups back ethanol, there...
...nstitute of Technology and Emory University have r...ence Foundation to establish "The Origins Project,...public outreach focused on the chemistry that may ...cludes the participation of Spelman College in Atl..., The NSF is supporting The Origins Project as pa...
Other Biology News:Eating competence may lower risk of heart disease 2Iowa State University conference examines developing bioeconomy 2Georgia Tech/Emory Center to study origin of life 2
(Date:11/25/2009)..., , BOSTON, Nov. 25 ...e H1N1 virus, genomic data from the 1918 pandemic ...the current H1N1 pandemic, today issued its latest...hows that the lethality of the H1N1 ("Swine Flu") ...during the virus,s current outbreak in the spring ...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 /PRNewswire/ -...earch report is available in its catalogue: ,, ...o 2013 ,, http://www.reportlinker.com/p016550...to-2013.html ,, Brazil Bioethanol Market Analy...e report provides detailed analysis and forecasts ...
(Date:11/24/2009)... The New York investment ...td (ASX:NEU) has agreed an AU$6.7 mil convertible ...nvestor. The private placement was arranged by KTA... advisor. , New York (PRW...investment bank KTA Capital, LLC ("KTA Capita...
(Date:11/24/2009)... Health care employment ...ains the only one to show consistent growth during...y hospitals remain in trouble, and health systems ...l personnel, instead of just administrators. , ... Health care employment continued growing in Octob...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...hnologies announced a new line of genotyping reag...Annual Clinical Virology Symposium in Florida. , ,...r disease in the United States and affects 4 milli...lly, according to a company statement. The new rea...llow labs to develop tests for the six different t...
...s Inc., a provider of services that help small bus...a web-based application that businesses can use to...sends e-mails to business owners reminding them of...s, as well as various meeting deadlines. , ,"Compl...es is often at the bottom of a long list of priori...
...n entrepreneur Ken Schlager started a company, he ...ces. This time around, Schlager is turning to the ...r help as he launches a cutting-edge technology th...eatment. , ,Schlager, a 75-year-old electrical eng...water and removes organic materials, while also di...
Other Biology Technology:CTT - Bridging the states entrepreneurial gap 2CTT - Bridging the states entrepreneurial gap 3
... System provides optimized reagents and protocols ... genes by insertion of group II introns. The metho...rons and utilizes a simple PCR step to re-target t...n into the host genome. Utility of the technology ...
Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Abnova Corporation
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
Biology Products: